Posted Feb. 8, 2013 at 8:55 a.m.

Premium Lock Tranzyme board decides to explore possible sale or merger

Published: 2013-02-08 08:55:00
Updated: 2013-02-08 08:55:00

Print this blog post

Drug development firm Tranzyme, its stock trading well under $1, has decided to explore a possible sale, merger or other options that can "maximize value to its stockholders."...

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Vivek Wadhwa
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science